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Abstract - HeLa cells containing the chloramphenicol acetyl transferase (CAT) gene under the 
control of the hsp70 promoter have been exposed in vitro to various anticancer drugs. Cisplatin 
induced CAT production with a dose-effect relationship at a non-cytotoxic dose, whereas no 
induction was detected with carboplatin. Etoposid induced a significant response at a cytotoxic 
concentration. The limited positive response with doxorubicin, daunomycin and mitoxantrone 
was not statistically significant. These chemicals are known to produce reactive oxygen species 
and induce apoptosis. No induction of the hsp70 promoter could be detected with the other 
cytostatic compounds that have been tested such as base analogs (5-fluorouracil, cytosine 
arabinoside 3'-MP), inhibitors of DNA synthesis (amethopterin, aminopterin), antimitotics 
(vinblastine, colchicine), and alkylating (streptozotocine, carboplatin, melphalan) or intercalating 
agents (bleomycin). In addition, the role of the transcription inhibitory activity of doxorubicin in 
this model is evidenced and the consequent question of the suitability of the reporter gene system 
is discussed. Our results suggest that specific genotoxic compounds are not able to induce the 
hsp70 promoter, and are in agreement with the concept that stimulation of HSP70 synthesis 
occurs through a biochemical process involving proteotoxicity.  
Keywords: hsp70 promoter; anticancer drug; HeLa cells. 
 
INTRODUCTION 
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A wide range of physical, chemical and biological agents are known to induce a set of cellular 
stress proteins, the heat-shock proteins (HSP). This occurs through a mechanism of toxicity 
involving the generation of denatured proteins by the stressors (Hightower, 1991) and resulting in 
the binding of a heat shock factor (HSF) to specific DNA sequences called heat shock elements. 
Among the different stress proteins, the HSP70 family is the most abundant and conserved. It has 
frequently been proposed as a biomarker of cellular toxicity (Fishbach et al., 1993; Ryan and 
Hightower, 1996). 
Anticancer drugs represent a growing threat in environmental health as reported by occupational 
exposure monitoring (Bos et al., 1998) and sewage water contamination by hospital effluents 
studies (Kümmerer and Helmers, 1997). Many studies showed expression of stress proteins in 
response to such agents (Bielka et al., 1994; Ciocca et al., 1993; Matsumoto et al., 1998). While 
in most cases the small HSPs (HSP27) rather than HSP70 are induced in response to these 
compounds, high intracellular levels of both HSPs induced by heat shock or constitutively 
overexpressed, are closely related to cellular resistance development against these drugs (Ciocca 
et al., 1993; Garrido et al., 1997; Roigas et al., 1998), hence posing problems in cancer therapy. 
In this study, we apprehended the use of an established transformed HeLa cell line, obtained by 
transfection with a plasmid construct carrying the human hsp70 promoter linked to the 
chloramphenicol acetyl transferase (CAT) gene (Kretz-Remy and Arrigo, 1994), as an in vitro 
toxicity test to screen various molecules widely used in cancer chemotherapy. The relationship 
between induction and the mechanism of toxic action of the substances is discussed. 
 
MATERIALS AND METHODS 
Chemicals. All chemicals were from Sigma (France) except carboplatin (Aldrich, France) and 
bleomycin sulfate (R. Bellon, Rhône Poulenc, France). 
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Cell cultures. Transformed HeLa cells were routinely cultured at 37°C in complete DMEM 
supplemented with 10% heat inactivated foetal bovine serum (Gibco, France) and 1% antibiotics 
in a humidified atmosphere containing 5% CO2. 
Induction of the hsp70 promoter. For the induction experiment, cells were seeded onto 24-well 
plates (Costar) in 1ml/well of complete prewarmed medium and allowed to grow for 3 or 4 days 
until they reached 80% confluency. At this stage, various dilutions of each toxicant, made in the 
solvent (DMSO or saline), were added to the culture medium, 24 hr after the last medium change. 
Cells were exposed for 16 hr at 37°C in the presence of serum. Control wells received the same 
concentration of solvent alone (never exceeding 0.5%). At the end of exposure, cells were washed 
twice with phosphate buffer saline, lysed and total cellular proteins were analysed using a CAT 
ELISA kit (Boehringer) according to the manufacturer's instructions. In each experiment, heat 
treatment (43°C, 1 hr), followed by a 24 hr recovery period, was used as a positive control. 
Results are expressed as the ratio between the amount of CAT detected and the total cellular 
protein content assessed by an adaptation of the Lowry's method (BioRad DC Protein Assay kit). 
Background level in control cultures varied from 0 to 20 pgCAT/mg protein, corresponding to the 
range of sensitivity of the assay. 
MTT assay. Cytotoxic concentrations were determined by the MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) reduction test. Cells were grown in 96-well microtiter plates 
until subconfluence and then exposed to toxicants as describe above. After chemical exposure, 
the monolayers were washed and incubated with 100µl of 0.5 mg/ml MTT dissolved in RPMI 
medium for 3 hr at 37°C, 5% CO2. MTT was removed and the formazen salt was solubilized, with 
mixing, in 100µl of isopropanol. Plates were read at 570 nm on a microtiter reader (BioTek 
Instruments). 
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RESULTS 
Induction of the hsp70 promoter 
In order to set the concentrations to be tested in hsp induction experiments, cytotoxicity of the 
substances was evaluated in preliminary experiments by using the MTT reduction test. Since the 
test is carried out on subconfluent cells, cytotoxicity can be the reflect of either growth inhibition 
or direct cell killing or both. For the HSP experiments, serial dilutions were made including 
cytotoxic and non cytotoxic concentrations determined by the MTT test. The effect of these 
concentrations on cell viability (cytotoxicity) was further confirmed by a total protein assay 
performed at the end of the HSP induction experiments. 
The tested toxicants showed different effects on the inducibility of the hsp70 promoter (table 1). 
Cisplatin induced the promoter significantly (p<0.05) at a concentration (10 µM) which had no 
significant effect on the cellular viability as measured by the total protein content and MTT assay 
(figure 1). Etoposid induced a significant response (p<0.05) at a cytotoxic concentration 
(400µM). A limited positive response was observed with doxorubicin, daunomycin and 
mitoxantrone but this appeared non statistically significant. No induction of CAT production was 
detected after exposure to 5-fluorouracil, cytosine arabinoside, amethopterin, aminopterin, 
colchicine, streptozotocine, bleomycin, carboplatin, melphalan and vinblastine. The preliminary 
MTT tests revealed that the first five compounds were the most cytotoxic, achieving 100% cell 
death at the highest concentrations tested (data not shown). Such a cytotoxicity was never 
obtained with the other substances at the tested concentrations (up to 10 mM for some toxicants). 
Case of inhibitors of transcription 
In order to test wether protein synthesis inhibition by some toxicants could mask the detection of 
CAT production, cells were exposed to a heat shock (43°C for 1 hr) in the presence of various 
concentrations of doxorubicine (known as a transcription inhibitor) or streptozotocin (alkylating 
agent, not suspected to inhibit specifically gene expression). Lysis of cells occurred five hours 
after the heat shock to minimise the toxic effect of the substances. The results (figure 2) showed 
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an inhibition of CAT production by doxorubicin while streptozotocine seemed to have no effect 
on hsp70 promoter expression after heat shock. Hence, we supposed that the weakness of the 
observed induction with toxicants like doxorubicin, daunomycin or mitoxantrone (table 1), could 
be explained by an inhibitory effect on gene transcription by these toxicants. Supplementary 
experiments (figure 3) including recovery periods of 6 and 24 hours after the exposure time 
showed a stronger CAT production by doxorubicin and thus confirmed our hypothesis. 
 
DISCUSSION 
Only a few data are available concerning HSP70 induction by cytostatics in comparison to 
HSP25, which seems to play a major role in cellular response to such drugs. For instance, 
bleomycin has been previously shown to induce the hsp70 promoter up to twice the control in 
hsp70- -galactosidase transfected fibroblasts (Moseley et al., 1989) whereas streptozotocine did 
not induce any HSP synthesis in murine splenocytes in vitro (Albers et al., 1996). Bielka et al. 
(1994) showed that HSP25, but not HSP70, was induced by cisplatin, doxorubicin, daunomycin, 
cytosine arabinoside and colchicine at concentrations with 100% cytostatic effect on Ehrlich 
ascites carcinoma cells. Aminopterin, 5-fluorouracil and amethopterin did not induce either stress 
protein synthesis. In contrast, 5-fluorouracil, adriamycin (doxorubicin) and cisplatin enhanced the 
expression of the Drosophila hsp70 promoter stimulated by heat shock in prostate carcinoma cells 
(Roigas et al., 1998). Cisplatin also stimulated HSP70 synthesis in human glioblastoma cells 
(Matsumoto et al., 1998) whereas in HeLa cells it provoked the migration of the protein to the 
nucleus without any enhancement of its synthesis (Melendez-Zajgla et al., 1996). 
To some extent, our results are correlated with these observations. Among the fifteen anticancer 
drugs that we have tested, only cisplatin, doxorubicin, daunomycin, mitoxantrone and etoposid 
were able to induce an activation of the hsp70 promoter (table 1, figure 1). Interestingly, MTT 
assays revealed that these compounds were the most cytotoxic after a 16 hour exposure (data not 
shown). In addition to their genotoxic effect by producing DNA damage, such as DNA adducts or 
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DNA intra- and interstrand crosslinks, these compounds have various direct biochemical effects 
like oxidative action, interaction with cellular proteins or apoptosis induction (Calabresi and 
Chabner, 1990; Chu, 1994; Sacchi and Schiaffonati, 1996).  
None of the other substances that we have tested in this study neither induced the hsp70 promoter 
(table 1) nor appeared to be strongly cytotoxic (data not shown) in our experiments. Cytosine 
arabinoside and 5-fluorouracil (base analogs) or amethopterin and aminopterin (inhibitors of 
DNA synthesis by inhibition of dihydrofolate reductase) act essentially as cytostatic agents. 
Vinblastine and colchicine act as antimitotic agents by interacting with the microtubule system. 
Streptozotocine, carboplatin and melphalan are alkylating agents, similarly to the intercalating 
agent bleomycin, that have a physical action on DNA. Our negative result with bleomycin is not 
in agreement with a previous observation (Moseley et al., 1989). It looks as if substances which 
exert specific effects, mostly at the DNA level, and which do not interact broadly with cellular 
proteins, are not able to induce hsp70 expression. 
Our findings suggest that, in our cellular model, the observed inductions of the hsp70 promoter 
are rather due to a cytotoxic action resulting either in protein denaturation and HSF activation or 
apoptosis, than to a cytostatic effect. This is in agreement with the concept that HSP70 is a 
marker of proteotoxicity (Hightower, 1991) rather than genotoxicity. 
A further important point to discuss concerns our experimental conditions. Cell lysis occurred at 
the end of the 16 hr exposure period. This time is theoretically sufficient to observe a stress 
protein synthesis after a cellular aggression if the gene expression machinery is not inhibited. The 
inhibitory action on DNA transcription by doxorubicin but not streptozotocine (figure 2), suggests 
that the poor induction observed in response to doxorubicin, daunomycin and mitoxantrone might 
have been strongly attenuated by their inhibitory action on gene expression. This effect is 
reversible since a significant CAT production was detected 6-hr after exposure to doxorubicin 
(figure 3) at concentrations where heat shock-induced CAT production is inhibited (figure 2). 
These observations showed that an assay based on the synthesis of marker protein is not quite 
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adapted to detecting these types of effect. Thus, examination of toxicant effect on heat shock 
induced CAT production would be a suitable control test to detect false negatives in the case of 
gene expression inhibitors. 
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*significantly different from untreated control (p<0.05, Dunnetts' test). a: mean values  S.E.M. b: n=number of 
independent experiments made in triplicate. From carboplatin to streptozotocine: c: no induction detected (values 
<20 pgCAT/mg protein); d: range of the tested concentrations; e: total protein content at the highest 
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Figure1. Induction of the hsp70 promoter and survival of HeLa cells after exposure to 
cisplatin for 16 hours. 
* significantly different from control cultures (p<0.05, Dunnetts' test). Values are means of three independent 













































































Figure 2. Effect of doxorubicin and streptozotocine on hsp70 promoter activation by heat shock. 
HeLa cells were submitted to a sublethal heat shock (43°C, 1hr) followed by a 5 hour incubation at 37°C in 
presence or not to various concentrations of doxorubicin and streptozotocine. Results are representative of two 
identical experiments made in triplicate. The total protein content in heat treated cultures was not significantly 






























































Figure 3. Induction of the hsp70 promoter by doxorubicin, 6 and 24 hours after a 16 hour 
exposure. 
* significantly different from control cultures (p<0.05, Dunnetts' test). Values are representative of two 
independent experiments made in triplicate. Bars: pg CAT/mg of total protein, lines: quantity of total protein (% 
of control). 
